127 related articles for article (PubMed ID: 3358248)
1. [Effects of oral tulobuterol on bronchial obstruction in asthmatic patients].
Vergeret J; Taytard A
Therapie; 1988; 43(1):21-4. PubMed ID: 3358248
[No Abstract] [Full Text] [Related]
2. Bambuterol: a new long acting bronchodilating prodrug.
Vilsvik JS; Langaker O; Persson G; Ringdal N; Schaanning J; Kvelstad G; Svensson K; Holthe S; Soliman S
Ann Allergy; 1991 Apr; 66(4):315-9. PubMed ID: 2014931
[TBL] [Abstract][Full Text] [Related]
3. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
Kobayashi Y; Yasuba H; Kudou M; Kita H
J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319
[TBL] [Abstract][Full Text] [Related]
4. [Effect of a patch formulation of tulobuterol on cough scores and PEF in patients with cough variant asthma].
Fujimori K; Suzuki E; Gejyo F
Arerugi; 2000 Aug; 49(8):658-61. PubMed ID: 11021018
[No Abstract] [Full Text] [Related]
5. [Oral therapy with beta-2-sympathomimetic drugs: comparative study of the bronchospasmolytic effect of tulobuterol and fenoterol in patients with reversible airway obstruction].
Morr H; Nink M; Ferlinz R
Pneumologie; 1990 Apr; 44(4):739-43. PubMed ID: 2192369
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the clinical efficacy of salmeterol and sustained-release tulobuterol (patch) on inadequately controlled asthma patients on inhaled corticosteroids.
Fujimoto K; Komatsu Y; Yasuo M; Urushihata K; Kubo K
J Asthma; 2006 Sep; 43(7):501-7. PubMed ID: 16939989
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Kume H; Shimokata K
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1016-21. PubMed ID: 17042908
[TBL] [Abstract][Full Text] [Related]
8. Comparison of adherence and efficacy between inhaled salmeterol and transdermal tulobuterol patch in elderly patients with chronic obstructive pulmonary disorder.
Sugawara T; Nanjo Y; Yamazaki M; Higashihara K; Tsuda Y; Mochizuki H; Noguchi T; Takahashi H
J Am Geriatr Soc; 2009 May; 57(5):919-20. PubMed ID: 19470012
[No Abstract] [Full Text] [Related]
9. Can oral beta2 agonists cause heart failure?
Jenne JW
Lancet; 1998 Oct; 352(9134):1081-2. PubMed ID: 9798578
[No Abstract] [Full Text] [Related]
10. [Broncholytic effect of salbutamol, ventolin and berotec aerosols in bronchial asthma].
Jagodziński J; Woźniakowska U
Pneumonol Pol; 1981; 49(10):695-701. PubMed ID: 7036102
[No Abstract] [Full Text] [Related]
11. [Efficacy and safety of tulobuterol patch versus oral salbutamol sulfate in children with mild or moderate acute attack of bronchial asthma: a comparative study].
Lin Q; Liu QH; Bao YX
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):462-5. PubMed ID: 23791063
[TBL] [Abstract][Full Text] [Related]
12. Salbutamol, terbutaline and pirbuterol allergy in an asthmatic patient.
Bonniaud P; Favrolt N; Collet E; Dumas JP; Guilloux L; Pauli G; Camus P
Allergy; 2007 Oct; 62(10):1219-20. PubMed ID: 17845596
[No Abstract] [Full Text] [Related]
13. Cost-effectiveness of inhaled beta-agonists v. oral salbutamol in asthma: a randomized double-blind cross-over study.
Thomas K; Peter JV; Cherian AM; Guyatt G
Natl Med J India; 1996; 9(4):159-62. PubMed ID: 8772331
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of tulobuterol on methacholine-induced bronchospasm in asthmatic children.
Riba A; Dal-Re R; Morell F
Eur J Clin Pharmacol; 1988; 35(1):77-9. PubMed ID: 3220098
[TBL] [Abstract][Full Text] [Related]
15. [Oral therapy of asthma. Studies on the effects of bronchodilators in tabelts].
Kamburoff PL; Prime FJ; Bianco S
Fortschr Med; 1972 Apr; 90(11):439-43. PubMed ID: 4680609
[No Abstract] [Full Text] [Related]
16. Tulobuterol in childhood asthma: single dose ranging and repeated oral dose comparative studies.
Javier MA; Noche ML
J Int Med Res; 1986; 14(5):228-35. PubMed ID: 2876923
[TBL] [Abstract][Full Text] [Related]
17. The importance of particle size in response to inhaled bronchodilators.
Rees PJ; Clark TJ; Morén F
Eur J Respir Dis Suppl; 1982; 119():73-8. PubMed ID: 6954090
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the effects of subcutaneous orciprenaline, salbutamol and terbutaline in asthmatic children.
Koivikko A
Ann Clin Res; 1974 Apr; 6(2):99-104. PubMed ID: 4837881
[No Abstract] [Full Text] [Related]
19. Effects of oral terbutaline in asthmatic patients. A dose response study.
Fagerberg E; Tegner KB
Scand J Respir Dis; 1972; 53(1):3-9. PubMed ID: 4559526
[No Abstract] [Full Text] [Related]
20. Comparison of oral salbutamol with reproterol in reversible airway obstruction.
Dubey GR; Dabholkar SV; Kamat SR; Mahashur AA; Shah SP; Sonaje AG; Athawale SS
J Assoc Physicians India; 1986 Mar; 34(3):179-82. PubMed ID: 3525508
[No Abstract] [Full Text] [Related]
[Next] [New Search]
